IN THIS EPISODE - What a peptide actually is, and why your GLP-1 is NOT the same thing as BPC-157 or TB-500 - The seven peptides the FDA is reviewing: BPC-157, KPV, TB-500 (the "Wolverine complex"), MOTS-c, DSIP, Semax, and Epitalon - The "funding gap" why peptides that can't be patented never get human clinical trials - Six things the FDA worries about in an unlabeled vial, from identity and purity to the cancer/angiogenesis risk - The two questions that tell you if a peptide provider is legitimate (503A/B pharmacies and third-party certificates of analysis) ABOUT THE GUEST Tanna Donalson is a Physician Assistant and Owner of Redbud Medical in Denver Colorado
Apoptosis and DNA damage mediated by ROS involved in male reproductive toxicity in mice induced by Nickel
Exercise, adequate sleep, and relaxing hobbies are all ways to help keep chronic stress away
doi: 10.2991/jegh.k.191028.001 2 BommerCSagalovaVHeesemannEManne-GoehlerJAtunRBrnighausenTet al
11 Private prescriptions Private prescriptions remain the primary route for most people
